LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $121,000 | +63.5% | 20,700 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | +131.2% | 21,700 | -3.1% | 0.00% | – |
| Q3 2020 | $32,000 | -5.9% | 22,400 | +30.2% | 0.00% | – |
| Q2 2020 | $34,000 | -46.9% | 17,200 | -48.2% | 0.00% | -100.0% |
| Q1 2020 | $64,000 | -60.7% | 33,200 | -15.7% | 0.00% | -50.0% |
| Q4 2019 | $163,000 | -78.0% | 39,400 | -84.0% | 0.00% | -77.8% |
| Q3 2019 | $742,000 | -54.3% | 246,700 | -4.5% | 0.01% | -57.1% |
| Q2 2019 | $1,624,000 | +17.0% | 258,300 | +3.4% | 0.02% | +10.5% |
| Q1 2019 | $1,388,000 | +577.1% | 249,700 | +708.1% | 0.02% | +850.0% |
| Q4 2018 | $205,000 | +81.4% | 30,900 | +191.5% | 0.00% | +100.0% |
| Q3 2018 | $113,000 | +117.3% | 10,600 | +140.9% | 0.00% | 0.0% |
| Q2 2018 | $52,000 | +67.7% | 4,400 | +100.0% | 0.00% | – |
| Q1 2017 | $31,000 | +6.9% | 2,200 | +4.8% | 0.00% | – |
| Q4 2016 | $29,000 | +222.2% | 2,100 | +320.0% | 0.00% | – |
| Q3 2016 | $9,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |